CINCOR PHARMA
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor’s lead program is CIN-107, a novel aldosterone synthase inhibitor.
CINCOR PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.cincor.com
Total Employee:
11+
Status:
Active
Total Funding:
418 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Microsoft Exchange Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Current Advisors List
Board_member
2022-01-01
Board_member
Current Employees Featured
Jon Isaacsohn CEO & Co Founder @ CinCor Pharma
CEO & Co Founder
Mason W. Freeman Executive VP Clinical Operations @ CinCor Pharma
Executive VP Clinical Operations
2021-10-01
Marc de Garidel CEO @ CinCor Pharma
CEO
2021-07-01
Catherine Pearce COO and Co-Founder @ CinCor Pharma
COO and Co-Founder
Founder
Stock Details
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - CinCor Pharma
Sofinnova Investments
Sofinnova Investments investment in Series B - CinCor Pharma
RTW Investments LLC
RTW Investments LLC investment in Series B - CinCor Pharma
General Atlantic
General Atlantic investment in Series B - CinCor Pharma
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - CinCor Pharma
BVF Partners
BVF Partners investment in Series B - CinCor Pharma
Omega Funds
Omega Funds investment in Series B - CinCor Pharma
Rock Springs Capital
Rock Springs Capital investment in Series B - CinCor Pharma
Perceptive Advisors
Perceptive Advisors investment in Series B - CinCor Pharma
Adage Capital Management
Adage Capital Management investment in Series B - CinCor Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-19 | CinCor Pharma Appoints Mason Freeman, M.D., as Executive VP, Clinical Development |
Official Site Inspections
http://www.cincor.com Semrush global rank: 2.86 M Semrush visits lastest month: 5.66 K
- Host name: ec2-98-83-184-133.compute-1.amazonaws.com
- IP address: 98.83.184.133
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CinCor Pharma"
About - CIRCOR
CIRCOR markets its solutions directly and through various sales partners to more than 14,000 customers in approximately 100 countries. The Company has a global presence with approximately 3,100 employees and is headquartered in …See details»
Leadership - CIRCOR
Before joining CIRCOR, Mr. Najjar served as Programs Manager, Business Development and Mergers & Acquisitions at Rockwell Collins, a multinational manufacturing company, from …See details»
CAD Leadership Team | CIRCOR Aerospace
Frédéric comes to CIRCOR from Aubert et Duval, where he was the Vice President and Head of the Nuclear, Oil & Gas, Defense and Specialties business unit. During his 9 year tenure, he …See details»
CIRCOR International - Crunchbase Company Profile
Circor International Inc. creates, manufactures, and sells technology products and subsystems. It reports two business segments: aerospace and defense and industrial. Circor primarily serves original equipment manufacturers (OEMs) …See details»
CIRCOR Announces CEO Transition - Business Wire
Jan 19, 2022 Contacts. Investor Contact Alex Maki Vice President, FP&A and Investor Relations CIRCOR International (781) 270-1200 Media Contacts Stephanie Pillersdorf Sard Verbinnen & Co. (212) 687-8080See details»
Document - SEC.gov
Burlington, Mass., July 26, 2022 – CIRCOR International, Inc. (NYSE: CIR) (“CIRCOR” or “the Company”), one of the world’s leading providers of mission critical flow control products and …See details»
Our Brands | CIRCOR
CIRCOR has built the business on strong products and services‚ those that lead the industry with specific pump and valve technologies and fluid handling solutions. While our Aerospace & …See details»
CIRCOR Company Profile - Office Locations, Competitors, Revenue …
CIRCOR has 1 employees across 32 locations and $786.92 m in annual revenue in FY 2022. See insights on CIRCOR including office locations, competitors, revenue, financials, executives, …See details»
CIRCOR Difference
CIRCOR leverages infrastructure logistics, raw-material access, and geographic proximity to provide high-value products and solutions to the many industries we serve. With strategically …See details»
CIRCOR Marks Launch of Employee Ownership Program - KKR
CIRCOR International, a leading provider of mission critical flow control products and services for the Industrial and Aerospace and Defense markets, recently became the latest KKR portfolio …See details»
Contact Us
Please provide as much detail as possible so that your request will be routed correctly. After submitting your request, you will be provided a case number.See details»
Partnership Innovates New Marine Scrubber Pump Application
The reason: Enforcement of the International Maritime Organization’s (IMO) global sulphur cap on emissions from commercial vessels, with an enforcement date of 1 January 2020. The cap …See details»
CinCor Pharma - Crunchbase Company Profile & Funding
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and …See details»
Careers - CIRCOR
CIRCOR is proud to support Military Makeover™ and its Operation Careers initiative. The U.S. military relies on CIRCOR for high-quality pumps, valves, actuators and other fluid control …See details»
Company CinCor Pharma, Inc. - MarketScreener.com
CinCor Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other …See details»
CinCor Pharma - Contacts, Employees, Board Members
Organization. CinCor Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
CinCor Pharma - Craft
CinCor Pharma is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic, and kidney diseases. It develops CIN-107, an oral small-molecule inhibitor of …See details»
CIRCOR International Announces Completion of Acquisition by …
Oct 18, 2023 CIRCOR International, Inc. (“CIRCOR” or the “Company”), one of the world’s leading providers of mission critical flow control products and services for the Industrial and …See details»
Numerator and Kantar Worldpanel Combine to Form New Global
4 days ago The new company's organization will be set up in compliance with local regulations. Contact Data Bob Richter Numerator 212-802-8588 press@numerator.com Contact ...See details»
Careers - CIRCOR Pumps
CIRCOR is proud to support Military Makeover™ and its Operation Careers initiative. The U.S. military relies on CIRCOR for high-quality pumps, valves, actuators and other fluid control …See details»